Allogeneic stem cell transplantation for patients with hematological malignancies using multiple unrelated cord blood units.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Busulfan; Ciclosporin; Cyclophosphamide; Fludarabine; Granulocyte colony-stimulating factors; Melphalan; Mycophenolate mofetil
- Indications Acute myeloid leukaemia; Chronic lymphocytic leukaemia; Chronic myeloid leukaemia; Graft-versus-host disease; Haematological malignancies; Myelodysplastic syndromes; Non-Hodgkin's lymphoma; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 07 Sep 2020 Biomarkers information updated
- 14 Feb 2013 Planned end date changed from 1 Apr 2013 to 1 Apr 2014 as reported by ClinicalTrials.gov.
- 26 Nov 2012 Planned End Date changed from 1 Dec 2011 to 1 Apr 2013 as reported by ClinicalTrials.gov.